NCT06578741View on ClinicalTrials.gov

GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis Post-Approval Study

NAEnrolling by invitationINTERVENTIONAL
Enrollment

300

Participants

Timeline

Start Date

November 25, 2024

Primary Completion Date

March 1, 2028

Study Completion Date

March 1, 2037

Conditions
Abdominal Aortic AneurysmPararenal Aortic AneurysmThoracoabdominal Aortic Aneurysm
Interventions
DEVICE

GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (TAMBE Device)

Treatment with the GORE® EXCLUDER® Thoracoabdominal Branch Endoprosthesis (TAMBE Device) in patients with Pararenal Abdominal Aortic Aneurysms and Thoracoabdominal Aortic Aneurysms

Trial Locations (1)

94305

Stanford Hospital, Stanford

All Listed Sponsors
lead

W.L.Gore & Associates

INDUSTRY